The second part of this comprehensive review of thrombolytic therapy in clnical medicien focuses on its use in a wide renge of thrombotic disorders, including pulmonary embolism, deep venous thrombosis, arterial thrombocmbolism, catheter-related thrombosis, arterial thrombocmbolism, catheter-relted thrombosis, and prosthetic valve occlusion. New experimental applications in the management of unstable angina and cerebrovascular disease are also discussed.
Get full access to this article
View all access options for this article.
References
1.
VetrovecGWLeinbachRCGoldHKCowleyMJ.Intra-coronary thrombolysis in syndromes of unstable angina: angiographic and clinical results. Am Heart J1982;104:946–952
2.
GotohKMinaminoTKatohO, et al. The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation1988;77:526–534
3.
AmbroseJAHjemdahl-MonsenCBorricoS, et al. Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction. J Am Coll Cardiol1987;9:1156–1165
4.
DeZwaanCBarFWJanssenJHA, et al. Effects of thrombolyic therapy in unstable angina: clinical and angiographic results. J Am Coll Cardiol1988;12:301–309
5.
UNASEM Collaborative Group.Thrombolytic agents in unstable angina (abstract). J Am Coll Cardiol1990;15:65A
6.
GulbaDJostSZwickyPLichtlenP.Thrombolytic therapy in unstable angina (abstract). J Am Coll Cardiol1988;12:48A
7.
GoldHKJohnsJALeinbachRC, et al. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation1987;75:1192–1199
8.
NicklasJMTopolEJKanderN, et al. Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina. J Am Coll Cardiol1989;13: 434–441
9.
TopolEJNicklasJMKanderNH, et al. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial. Am J Cardiol1988;62:368–371
10.
SchreiberTLMacinaGMcNultyA, et al. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction. Am J Cardiol1989;64:840–844
11.
SaranRKBhandariKNarainVS, et al. Intravenous streptokinase in the management of a subset of patients with unstable angina: a randomized controlled trial. Int J Cardiol1990;28:209–213
12.
TherouxPOuimetHMcCansJ, et al. Aspirin, heparin or both to treat acute unstable angina. N Engl J Med1988;319:1105–1111
13.
The RISC Group.Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet1990;336:827–830
14.
Neri SerneriGGGensiniGFPoggesiL, et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet1990;335:615–618
15.
SteffeninoGDiLeoMBergeroneS, et al. No clinical benefit from early intracoronary streptokinase in unstable angina: a prospective, randomized study (abstract). Eur Heart J1990;11:387
16.
BrochierMLRaynaudPRiouxP, et al. Thrombosis and thrombolysis in unstable angina. Am J Cardiol [B]1991;68:105–109
17.
ChaudharyHCrozierIHamerA, et al. Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina. Am J Cardiol1992;69:173–175
18.
WlliamsDOTopolEJCaliffRM, et al. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris: results of a placebo-controlled, randomized trial. Circulation1990;82:376–383
19.
FreemanMRLangerAWilsonRF, et al. Thrombolysis in unstable angina: randomized double-blind trial of t-PA and placebo. Circulation1992;85:150–157
20.
LilienfeldDEChanEEhlandJ, et al. Mortality from pulmonary embolism in the United States: 1962-1984. Chest1990;98:1067–1072
21.
TerrinMGoldhaberSZThompsonB, The TIPE investigators. Selection of patients with pulmonary embolism for thrombolytic therapy: thrombolysis in pulmonary embolism (TIPE) patient survey. Chest1989;95(suppl):279S–282S
22.
GoldhaberSZ.Thrombolysis for pulmonary embolism. Prog Cardiovasc Dis1991;34:113–134
23.
MarderVJBellWR.Fibrinolytic therapy. In: ColmanRWHirshJMarderVJSalzmanEW, eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott, 1987:1393–1437
24.
The urokinase pulmonary embolism trial: a national cooperative study. Circulation1973;47(suppl II):1–108
25.
Urokinase-streptokinase pulmonary embolism trial: phase II results. JAMA1974;229:1606–1613
26.
SharmaGVRKBurlesonVSSasaharaAA.Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism. N Engl J Med1980;303:842–845
27.
SharmaGVRKFollandEDMclntyreKMSasaharaAA.Long-term hemodynamic benefit of thrombolytic therapy in pulmonanary embolic disease (abstract). J Am Coll Cardiol1990:15:65A
28.
GoldhaberSZVaughanDEMarkisJE, et al. Acute pulmonary embolism treated with tissue plasminogen activator. Lancet1986;2:886–889
29.
VerstraeteMMillerGAHBounameauxH, et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation1988;77:353–360
30.
GoldhaberSZKesslerCMHeitJ, et al. Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet1988;2:293–298
31.
PrewittRMHoyCKongA, et al. Thrombolytic therapy in canine pulmonary embolism: comparative effects of urokinase and recombinant tissue plasminogen activator. Am Rev Respir Dis1990;141:290–295
32.
KesslerCM.Modern treatment of pulmonary embolism. Lung1990;168(suppl):841–848
33.
LansingAMDavisWM.Five year follow-up of iliofemoral venous thrombectomy. Ann Surg1968;168:620–628
34.
BarnerHBWilliamVLKaiserGCHanlonCR.Thrombectomy for iliofemoral venous thrombosis. JAMA1969;208:2442–2446
35.
ImmelmanEJJeffreyPC.The postphlebitic syndrome: pathophysiology, prevention and management. Clin Chest Med1984;5:537–550
36.
SherryS.Thrombolytic therapy for deep venous thrombosis. Semin Intervent Radiol1985;2:331–337
37.
GormsenJLaursenB.Treatment of acute phlebothrombosis with streptase. Acta Med Scand1967;181:373–383
38.
RogersLQLutcherCL.Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med1990;88:389–395
39.
HessH.Symposium Über Thrombolyse-Therapie, München. Stuttgart: Springer-Verlag, 1967
40.
DuckertFMüllerGNymanD, et al. Treatment of deep venous thrombosis with streptokinase. Br Med J1975;1:479–481
41.
MartinMFiebachBJO.Short-term ultrahigh streptokinase treatment of chronic arterial occlusions and acute deep vein thrombosis. Semin Thromb Hemost1991;17:21–38
42.
KakkarVVLawrenceD.Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis: a prospective study. Am J Surg1985;150(suppl 4A):54–63
43.
GoldhaberSZBuringJELipnickRJHennekensCH.Pooled analysis of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med1984;76:393–397
44.
National Institutes of Health Consensus Development Conference.Thrombolytic therapy in thrombosis: a National Institute of Health Consensus Development Conference. Ann Intern Med1980;93:141–144
45.
SchulmanS.Studies on the medical treatment of deep vein thrombosis. Acta Med Scand1985;704(suppl):1–68
46.
GoaKLHenwoodJMStolzJF, et al. Intravenous streptokinase: a reappraisal of its therapeutic use in myocardial infarction. Drugs1990;39:693–719
47.
PerssonAVPerssonCA.Thrombolytic therapy for deep vein thrombosis. Am J Surg1985;150:50–53
48.
GraorRAYoungJRRisiusB.Comparison of cost effectiveness of streptokinase and urokinase in the treatment of deep vein thrombosis. Ann Vasc Surg1987;1:524–528
49.
MannucciPM.Thrombolytic therapy of acute deep vein thrombosis of the lower limbs: choices, indications and limits. Ricera in Clinica ein Laboratorio1984;14:593–599
50.
TrübesteinGTrübesteinRLudwigM, et al. Fibrinolytic therapy with streptokinase and urokinase in deep vein thrombosis. Vasc Med1985;3:72–78
51.
TurpieAGGLevineMNHirshJ, et al. Tissue plasminogen activator versus heparin in deep vein thrombosis: results of a randomized trial. Chest1990;97(suppl):172S–175S
52.
ZimmermanRGürsoyAHornA, et al. Fibrinolytic therapy of deep vein thrombosis with continuous infusion of recombinant tissue plasminogen activator. Semin Thromb Hemost1991;17:48–54
53.
LevineMNWeitzJTurpieAGG, et al. A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease. Chest1990;97(suppl):168S–171S
54.
ZajkoABReillyJJBronKM, et al. Low-dose streptokinase for occluded Hickman catheters. Am J Radiol1983;741:1311–1312
55.
BlalockHAHillRSClarkeAG, et al. Use of modified subcutaneous right-atrial catheter to venous access in leukemic patients. Lancet1980;1:993–994
56.
CollinsRNBraunPAZinnerSHKassEH.Risk of local and systemic infection with polyethylene intravenous catheters. N Engl J Med1968;279:340–343
SmithNLRavoBSoroffHSAli KhanS.Successful fibrinolytic therapy for special vena cava thrombosis secondary to long-term parenteral nutrition. J Parenter Enteral Nutr1985;9:55–57
59.
DelophaneDScottJPRiggsTW, et al. Urokinase therapy for a catheter-related right atrial thrombosis. J Pediatr1982;100:149–152
60.
BernMMLokichJJWallachSR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med1990;112:423–428
61.
LawsonMBottinoJCHurtubiseMR.The use of urokinase to restore patency of occluded central venous catheters. Am J Intraven Ther Clin Nutr1982;9:29–32
62.
HurtubiseMRBottinoJCLawsonMMcCredieKB.Restoring patency of occluded central venous catheters. Arch Surg1980;115:212–213
63.
GlynnMFXPathNRCLangerB.Therapy of thrombotic occlusion of long-term intravenous alimentation catheter. J Parenter Enteral Nutr1980;4:387–390
WinthropALWessonDE.Urokinase in the treatment of occluded central venous catheters in children. J Pediatr Surg1984;19:536–538
66.
GaleGBO'ConnorDMChuJStanleyD.Restoring patency of thrombosed catheters with cryopreserved urokinase. J Parenter Enteral Nutr1984;8:298–299
67.
MonturoCADickersonRNMullenJL.Efficacy of thrombolytic therapy for occlusion of long term catheters. J Parenter Enteral Nutr1990;14:312–314
68.
AtkinsonJBBagnallHAGompertsE.Investigational use of tissue plasminogen activator for occluded central venous catheter. J Parenter Enteral Nutr1990;14:310–311
69.
WarrenRLSchlantRCWengerNKGalambosJT.Treatment of Budd-Chiari syndrome with streptokinase (abstract). Gastroenterology1973;64:200
70.
RoweJMRasmussonRLMaderSL, et al. Successful throm-bolytic therapy in two patients with renal vein thrombosis. Am J Med1984;77:1111–1114
71.
BullowCRWalkerWGBellWRGatewoodOB.Streptokinase salvage of renal vein thrombosis. Ann Intern Med1984;100:237–238
72.
SholarPMBellWR.Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med1985;103:539
73.
BrogdenRNSpeightTMAveryGS.Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses. Drugs1973;5:357–445
74.
Metzler de Höhmann-WeigelinG.Fibrinolyse und anti-koagulantion therapie bei retinalen Venenverschlüssen. Die Medizinische Verlagsgesellschaft. Marburg: Lohn, 1977
75.
Den OttolanderGJHCreondykA.Treatment of thrombosis of the central vein with streptokinase. Thomb Diath Haemorrh1968;20:415–419
76.
KohnerEMPettitJEHamiltonAM, et al. Streptokinase in central retinal occlusion: a controlled clinical trial. Br Med J1976;1:550–553
77.
AmeryADelootWVermylonJVerstraeteM.Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinase. Br Med J1970;4:639–644
78.
DotterCTRoschJSeamanAJ.Selective clot lysis with low dose streptokinase. Radiology1974;111:31–37
79.
OlinJWGraorRA.Thrombolytic therapy in the treatment of peripheral arterial occlusions. Ann Emerg Med1988;17:1210–1215
80.
McNamaraTOFischerJR.Thrombolysis of peripheral arterial and graft occlusions: improved results using high dose urokinase. Am J Radiol1985;144:769–775
81.
BelkinMBelkinBBuckhamCA, et al. Intra-arterial fibrinolytic therapy: efficacy of streptokinase vs urokinase. Arch Surg1986;121:769–773
82.
Van BredaAKatzenBTBatschAF.Urokinase versus streptokinase in local thrombolysis. Radiology1987;165:109–111
83.
KoltunWAGardinerGAHarringtonDP, et al. Thrombolysis in the treatment of peripheral arterial vascular occlusions. Arch Surg1987;122:901–905
84.
McNamaraTOBombergerRAMerchantRF.Intra-arterial urokinase as the initial therapy for acutely ischemic lower limbs. Circulation1991;836(suppl I):106–119
85.
SullivanKLGardinerGAKandarpaK, et al. Efficacy of thrombolysis in infrainguinal bypass grafts. Circulation1991;83(suppl I):99–105
86.
WhittemoreADClowesAWCouchNPMannickJA.Secondary femoropopliteal reconstruction. Ann Surg1981; 193:35–42
87.
GreenRMOurielKRicottaJJDeWeeseJA.Revision of failed infrainguinal bypass graft: principles of management. Surgery1986;100:646–653
88.
GraorRARisiusBLucasFU, et al. Thrombolysis with re-combinant human tissue-type plasminogen activator in patients with peripheral artery and bypass-graft thrombosis. Circulation1986;746(suppl I):15–20
89.
GraorRARisiusBYoungJR, et al. Thrombolysis of peripheral arterial bypass grafts: surgical thrombectomy compared with thrombolysis. A preliminary report. J Vasc Surg1988;7:347–355
90.
HessHMietschkAIngrischH.Niedrig dosiert thrombolyse zur Wiederherstellung der Strombahn bei arteriellen Verschlussen. Dtsch Med Wochenschr1980;105:787–791
91.
RothFJRieserRSchefflerAKringsW.Intra-arterial fibrinolytic therapy of chronic arterial occlusions. Semin Thromb Hemost1991;17:39–47
92.
MathiasK.Local thrombolysis for salvage of occluded by-pass grafts. Semin Thromb Hemost1991;17:14–20
93.
RutherfordRBFlaniganDPGuptaSK, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg1986;4:80–94
94.
VanBreda A.Thrombolysis in arterial bypass grafts. Semin Thromb Hemost1991;17:7–13
95.
RicottaJJGreenRMDeWeeseJA.Use and limitations of thrombolytic therapy in the treatment of peripheral arterial ischemia: results of a multi-institutional questionnaire. J Vasc Surg1987;6:45–50
96.
FischerCPKannokJWChoRJ, et al. Renal artery embolism: therapy with intra-arterial streptokinase infusion. J Urol1981;125:402–404
97.
SteckelAJohnstonJFraleyDS, et al. The use of streptokinase to treat renal arterial thromboembolism. Am J Kidney Dis1984;4:166–170
98.
ContractorFMLeichtJP.Intra-arterial infusion of low dose streptokinase after acute thromboembolization of the right renal artery. Cardiovasc Intervent Radiol1984;7:21
99.
AdlerJIbrahimIMGoldmanMThomashowDF.Combined thrombolysis with low-dose streptokinase and angio-plasty in the treatment of renal artery occlusion. Urol Radiol1983;5:113
100.
FlickingerEGJohnsrudeISOgburnNL., et al. Local streptokinase infusion for superior mesenteric artery thromboembolism. Am J Roentgenol1983;140:771–772
101.
KwaanH.Thromboembolic disorders of the eye in thrombolytic therapy. In: CamerotaAJ, ed. Thrombolytic therapy. New York: Grune and Stratton, 1988:153–163
102.
LuluagaITCarreraDD'OlivieraJ, et al. Successful thrombolytic therapy of valve prosthesis after acute tricuspid valve obstruction. Lancet1971;1:1067–1068
103.
GraverLMGelberPMTyrasDH.The risks and benefits of thrombolytic therapy is acute aortic and mitral prosthetic valve dysfunction: report of a case and review of the literature. Ann Thorac Surg1988;46:85–88
104.
RoudautMLLedainLRoudautR, et al. Thrombolytic treatment of acute thrombotic obstruction with disk valve prosthesis: experience with 26 cases. Semin Thromb Hemost1987;13:201–205
105.
VisserCAKanGLieKlDurrerD.Left ventricular thrombus following acute myocardial infarction: a prospective serial echocardiographic study of 96 patients. Eur Heart J1983;4:333–337
106.
AsingerRWMikellFLElspiegerJHodgesM.Incidence of left ventricular thrombus after acute transmural myocardial infarction. N Engl J Med1981;305:297–302
107.
TramarinRPozzoliMFeboO, et al. Echocardiographic assessment of therapy efficacy in left ventricular thrombosis post myocardial infarction (abstract). Circulation1983;68(suppl III):331
108.
KremerPFiebigRTilsnerV, et al. Lysis of left ventricular thrombi with urokinase. Circulation1985;72:112–118
109.
HachinskiV.Deceased incidence and mortality of stroke. Stroke1984;15:376–378
110.
SolisOJRobersonGRTaverasJM.Cerebral angiography in acute cerebral infarction. Revista Interamer Radiol1977;2:19–25
111.
SussmanBJFitchTSP.Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA1958;167:1705–1709
112.
SloanMA.Thrombolysis and stroke: past and future. Arch Neurol1987;44:748–768
113.
Del ZoppoGJFerbertAOtisS, et al. Local intraarterial fibrinolytic therapy in acute carotid territory stroke. Stroke1988;19:307–313
114.
ZeumerHFreitagHJGrzyskaUNeunzigHP.Local intraarterial fibrinolysis in acute vertebrobasilar occlusion: technical developments and recent results. Neuroradiology1989;31:336–340
115.
MoriETabuchiMYoshidaTYamadoriA.Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke1988;19:802–812
116.
TheronJCourtheouxPCasascoA.Local intraarterial fibrinolysis in the carotid territory. Am J Neuroradiol1989;10:753–765
117.
HackeWZeumerHFerbertA, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebro-basilar occlusive disease. Stroke1988;19:1216–1220
118.
BrottTHaleyECLevyDE, et al. The investigational use of tPA for stroke. Ann Emerg Med1988;17:1202–1205
119.
ZivinJALydenPDDeGirolamiU, et al. Tissue plasminogen activator: reduction of neurologic damage after experimental embolic stroke. Arch Neurol1988;45:387–391
120.
DiRoccoCIannelliALeoneG, et al. Heparin-urokinase treatment in aseptic dural sinus thrombosis. Arch Neurol1981;38:431–435
121.
KrayenbuhlHA.Cerebral venous and sinus thrombosis. Clin Neurosurg1967;14:1–24
122.
HigashidaRTHelmerEHalbachVVHieshimaGB.Direct thrombolytic therapy for superior sagittal sinus thrombosis. Am J Neuroradiol1989;10(suppl):4–6
123.
ScottJAPascuzziRMHallPVBeckerGJ.Treatment of dural sinus thrombosis with local urokinase infusion. J Neurosurg1988;68:284–287
124.
BarnwellSLHigashidaRTHalbachVV, et al. Direct endovascular thrombolytic therapy for dural sinus thrombosis. Neurosurgery1991;38;135–142
125.
AlexanderLFYamamotoYAyoubiS, et al. Efficacy of tissue plasminogen activator in the lysis of thrombosis of cerebral venous sinus. Neurosurgery1990;26:559–564
